NOVACYT Aktie

 

PARIS & CAMBERLEY, England--(BUSINESS WIRE)--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) ("Novacyt" or the "Company" or the "Group"), an international specialist in clinical diagnostics, announces that James McCarthy has been appoint...

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...

FRANKFURT (Dow Jones)--Europas Börsen weisen auch am Montagnachmittag erhebliche Verluste aus. Der Kursrutsch wird ausgelöst durch eine vor allem in Großbritannien aufgetauchte Virus-Mutation. Diese ist nach ersten Erkenntnissen bis zu 70 Prozent ...

Novacyt SA (LON:NCYT) said its tests can detect the new coronavirus (COVID-19) strain found by the Genomics UK consortium. The diagnostics firm said it carried out a detailed analysis of the mutations in this new variant and in all published COVID-19...

Novacyt SA (LON:NCYT) said its tests can detect the new COVID-19 strain found by the Genomics UK consortium. The diagnostics firm said it carried out a detailed analysis of the mutations in this new variant and in all published COVID-19 strains to co...

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...

Since Novacyt shares have pulled back, a number of top-level directors have purchased stock. This suggests these insiders are confident, but am I? The post Novacyt shares: insiders are buying. Should I buy too? appeared first on The Motley Fool UK....

A £3,000 investment in January 2020 would have inflated to just over £257,000 with Novacyt. But the stock's been volatile lately, so would I buy it now? The post Should I buy Novacyt shares for the long term or are they risky now? appeared first o...

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...

Novacyt SA (LON:NCYT), one of the glamour stocks of the first half of this year, continued its fall from the heavens after a research & development update. Shares in the international specialist in clinical diagnostics fell 11% to 800p, although whet...

Paris-based diagnostics group Novacyt said encouraging interim data had been reported from an ongoing clinical trial in care homes that was assessing the accuracy of its Covid-19 test. Queen Mary University of London had completed an interim review o...

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...

Novacyt SA (LON:NCYT) plunged 40% to 628p on Monday in the wake of news about the Pfizer/BioNTech coronavirus (COVID-19) vaccine. The shares have been on an astonishing run this year, rising from 13p at the end of 2019 to 1,050p overnight on the back...

BP plc (LON:BP), Novacyt SA (LON:NCYT) and Boohoo Group plc (LON:BOO) shares topped the buy table last week. Should I should follow the money? The post Hargreaves Lansdown investors are buying BP, Novacyt and Boohoo shares. Should I? appeared first o...

Novacyt, a France-based biotechnology company whose Primerdesign outpost in Southampton designed one of the first Covid tests in January and is now supplying the world with kits....

Covid 19 testing is ramping up. Harshil Patel discusses a diagnostics leader and what the Novacyt share price might do next. The post The Novacyt share price is flying: here's what I'd do next appeared first on The Motley Fool UK....

Um den gesamten Artikel unter morningstar.co.uk zu lesen, klicken Sie bitte auf die Überschrift...

The price of Novacyt stock has soared, but I think its success in coronavirus tests has laid the groundwork for an even better future. The post The Novacyt share price is up over 10,000% but I still think it’s a buy appeared first on The Motley Foo...

The Novacyt share price has made early investors rich. Is the Covid-19 testing firm still a buy in 2020? Tom Rodgers investigates. The post Interested in the Novacyt share price? Read this first! appeared first on The Motley Fool UK....